info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ticagrelor Companies

Several pharmaceutical companies were involved in the production and distribution of ticagrelor. It's important to note that the status of companies and the pharmaceutical landscape can change.Ticagrelor is an antiplatelet medication commonly used to prevent blood clots in individuals with acute coronary syndromes.

Ticagrelor Key Companies

 

Latest Ticagrelor Companies Update:

AstraZeneca Partnered with Sun Pharmaceutical Industries Ltd. to distribute Axcer, AstraZeneca's new brand of Ticagrelor, in India. This aims to boost accessibility and usage in a key market. Entered into a collaboration with the International Society for Thrombosis and Haemostasis (ISTH) to develop educational resources and programs for healthcare professionals on the optimal use of Ticagrelor.


Generic players Several companies like Sun Pharma, Zydus Cadila, Glenmark Pharmaceuticals, and Cipla have launched their generic versions of Ticagrelor in different markets, leading to increased competition and potential price reductions. The generic entry is expected to significantly impact AstraZeneca's market share, particularly in cost-sensitive regions.


List of Ticagrelor Key companies in the market



  • AstraZeneca

  • Eli Lilly

  • Ingelheim

  • Alexion

  • Roche

  • Amgen

  • Boehringer

  • Pfizer

  • Merck

  • GSK

  • Boehringer

  • Amgen

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.